Akti

Akt inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Akti, covering 2017-07-27 to 2017-07-27. Get the full timeline:

Most recent: Clinical Trial Update: In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma [Phase 1]